5 -Training and educational capacity to build competencies
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | ||
|---|---|---|
Name |
TREAT-NMD - Neuromuscular Network |
|
| Evidence of collaboration with regulatory authorities | Yes | TREAT-NMD has since its inception worked closely with regulators including the EMA. Several workshops have been held at and organised with the EMA. Most recently a workshop was organised by SMA and EMA, entitled "EMA Workshop - Development of Therapies for the Treatment of Spinal Muscular Atrophy" in November 2016. Similar workshops focusing on Duchenne muscular dystrophy have been organised previously. |
| Capacity to provide competent consultation to regulatory authorities | Yes | Both Members of the Steering Committee as well as the Secretariat serve on standing scientific committees including the Interdisciplinary Scientific Committee of the International Rare Diseases Research Consortium (IRDiRC) and the World Muscle Society.TREAT-NMD has organised several meetings hosted by and at the EMA, focusing on DMD and SMA. |
| Formal meetings for clinical trials | No | |
| Training courses given over the last 2 years | Yes | TREAT-NMD has organised 2 NMD-focussed Masterclasses in the last two years. Please find links to reports about the Masterclasses: http://www.treat-nmd.eu/events/653/ and http://www.treat-nmd.eu/newsletter/archive/email/31st_May_2017.html |
| Training courses received over the last 2 years | No | |
| Promotion of participation in clinical trials in countries with limited resources | No | |
| List of Countries |